Amlodipine And Valsartan Tablet
Product Images NDC 51407-773

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 51407-773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 11)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 11)
A line graph comparing the percentage of subjects with systolic blood pressure below 140 mmHg over a range of baseline systolic blood pressures (140 to 180 mmHg). Four treatment groups are shown: Valsartan 320 mg, Amlodipine 10 mg, Amlodipine and Valsartan 10/320 mg, and placebo, each represented by different symbols and lines.*
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 12)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 12)
A line graph displaying the percentage of subjects with diastolic blood pressure (DBP) under 90 mmHg plotted against baseline DBP (mmHg). It compares four groups: Valsartan 320 mg, Amlodipine 10 mg, Amlodipine and Valsartan 10/320 mg combination, and placebo, illustrating their relative effectiveness in lowering DBP.*
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 13)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 13)
A line graph comparing the percentage of patients achieving systolic blood pressure below 130 mmHg across different baseline systolic blood pressures (mmHg). It includes four treatment groups: Valsartan 320 mg, Amlodipine 10 mg, Amlodipine and Valsartan 10/320 mg, and Placebo, depicted with different markers.*
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 14)

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (00cf9c79 C9d7 42a7 9208 404fcee14f11 14)
A line graph showing the percentage of diastolic blood pressure (DBP) less than 80 mmHg versus baseline DBP in mmHg. The graph compares four groups: valsartan 320 mg, amlodipine 10 mg, amlodipine and valsartan 10/320 mg, and placebo, each represented by different symbols on the plot.*
FDA Label Image

Amlodipine Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 15)

Amlodipine Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 15)
Chemical structure diagram of the active ingredients amlodipine and valsartan, showing the molecular arrangement and bonding of both compounds.*
FDA Label Image

Valsartan Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 16)

Valsartan Chemical Structure (00cf9c79 C9d7 42a7 9208 404fcee14f11 16)
Chemical structure of amlodipine, one of the active ingredients in the Amlodipine and Valsartan tablet. The structure shows the molecular arrangement including a dihydropyridine ring and various substituents.*
FDA Label Image

51407-771-30ol (Rev 06-23.jpg)

51407-771-30ol (Rev 06-23.jpg)
Label of Amlodipine and Valsartan 5 mg/160 mg oral tablets, containing 30 tablets per bottle. The label includes dispensing instructions for pharmacists, storage conditions, and a reminder to keep medication out of children's reach. Marketed by GSMS, Incorporated, Camarillo, CA, USA. The label features a barcode and a QR code area for lot and expiration information.*
FDA Label Image

51407-772-30ol (Rev 06-23.jpg)

51407-772-30ol (Rev 06-23.jpg)
Amlodipine and Valsartan Tablets 5 mg/320 mg oral medication label by Golden State Medical Supply, Inc. The label indicates a package of 30 tablets with the NDC 51407-772-30. It includes pharmacist dispensing instructions, storage temperature details, dosage reference, and a barcode.*
FDA Label Image

51407-773-30ol (Rev 06-23.jpg)

51407-773-30ol (Rev 06-23.jpg)
Label for Amlodipine and Valsartan tablets, 10 mg/160 mg strength, oral dosage form. The label includes the NDC 51407-773-30, shows 30 tablets in the package, and states Rx Only. It is marketed by GSMS, Incorporated, Camarillo, CA. The label also contains storage instructions, ingredients, and a barcode.*
FDA Label Image

51407-774-30ol (Rev 06-23.jpg)

51407-774-30ol (Rev 06-23.jpg)
Label for Amlodipine and Valsartan tablets, 10 mg/320 mg strength, distributed in a bottle of 30 tablets. The label includes the NDC number 51407-774-30 and states it is for prescription use only. It provides patient information instructions and storage conditions. Marketed by GSMS, Incorporated, Camarillo, CA.*
FDA Label Image
Image Description (Avet Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.